ÆüËÜÇÀ·Ý²½³Ø²ñ 2025ǯÅÙÂç²ñ¥×¥í¥°¥é¥à¸¡º÷

¥×¥í¥°¥é¥à½¸PDF Âç²ñ¥È¥Ã¥×¥Ú¡¼¥¸¤ËÌá¤ë
¿ä¾©¥Ö¥é¥¦¥¶¡§Chrome¡¢FireFox¡¢Edge¡¢Safari
(Internet Explorer¤Ç¤ÏÀµ¤·¤¯É½¼¨¤µ¤ì¤Ê¤¤¾ì¹ç¤¬¤¢¤ê¤Þ¤¹)
Recommended browsers: Chrome, FireFox, Edge, Safari
(May not display correctly in Internet Explorer)
3D093
°ìÈֱ̹é
¥Ý¥¹¥¿¡¼¡¦Å¸¼¨²ñ¾ì
Æý»À¶ÝLP22A-3¤Î¥¢¥ì¥ë¥®¡¼À­±ê¾ÉÍÞÀ©¸ú²Ì
The oral administration of Lactiplantibacillus plantarum (LP22A-3) suppresses an allergic inflammation
³¤Ìî ¶Á±û²Â1¶áß· ̤Êâ1úɸ¶ ¹ÀÀ¿2ÅÄÀî ³Ù2»³Ì¾ Èþ¹¾2¿åÌî ²í»Ë3¡ûÌ« ·ò°ìϺ1
Kyoka UNNO1 Miho CHIKAZAWA1 Hiroshige KUWAHARA2 Takashi TAGAWA2 Yoshie YAMANA2 Masashi MIZUNO3 ¡ûKenichiro MINATO1
1̾¾ëÂçÇÀ¡¢2´ÝÁ±À½ÌôÁí¹ç¸¦µæ½ê¡¢3ÂçºåÀÄ»³Âç·ò¹¯²Ê³Ø
1Meijo Univ., 2Maruzen Pharmaceuticals Co., 3Osaka Aoyama Univ.
Lactiplantibacillus plantarum / anti-inflammation / allergy